BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) Key Ratios
$16.93
As on 04-Sep-2026 13:40EDT
Market cap
$1,059 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
6.6
P/B Ratio
1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | 33.71 | 193.79 | -26.11 | -26.69 |
| EBIT | -- | -- | 10.90 | -25.54 | -- |
| Net Profit | -- | -358.33 | 17.17 | -26.52 | -27.01 |
| EPS | -- | -371.75 | 23.26 | -- | -- |
| Book Value | -- | -- | 37.47 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| 157.72 | 143.09 | 101.50 | 268.87 | 102.81 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 0.84 | 1.83 | 3.46 | 3.37 | -4.32 |
| Return on Capital
| 0.84 | 1.83 | 3.46 | 3.37 | -4.32 |
| Return on Assets
| 0.84 | 3.87 | 3.42 | 3.33 | -4.22 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
3.46
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
3.46
|
3.37
|
-4.32
|
3.24
|
3.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
3.46
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
3.46
|
3.37
|
-4.32
|
3.24
|
3.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
3.42
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
3.42
|
3.33
|
-4.22
|
9.83
|
6.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
101.50
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
101.50
|
268.87
|
102.81
|
99.18
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
97.44
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
97.44
|
244.30
|
101.93
|
99.09
|
1,517.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
1.94
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
1.94
|
1.32
|
-1.44
|
10.38
|
-0.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
10.90
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
10.90
|
182.51
|
-145.12
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
17.17
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
17.17
|
175.62
|
-144.78
|
-25.69
|
-29.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.23
--
Year on year growth in earnings per share
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
0.23
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
--
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
--
|
--
|
--
|
0.00
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
313,228.00
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
313,228.00
|
400,548.64
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
4.97
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
4.97
|
19.24
|
-9.12
|
5.33
|
7.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.04
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
0.04
|
0.01
|
-0.04
|
0.10
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
21.03
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
21.03
|
87.93
|
-39.00
|
10.88
|
33.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
--
|
-10.06
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
8.14
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
8.14
|
10.21
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.25
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
0.25
|
0.35
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
177.53
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
177.53
|
10.20
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|